Denali Therapeutics Inc.
DNLINasdaqMid CapHealthcare
13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)
Key Metrics
Top Institutional Holders
as of Q2 2026$416.12M+89.9%
$360.76M+7.6%
$307.62M-0.9%
$181.31M+12.4%
$180.37M0.0%
$166.59M+5.8%
$161.41M+2.1%
$116.66M-0.9%
$106.89M-5.7%
$102.21M+6.6%
Financial Trends
Revenue & Net Income
Earnings Per Share
Loading ratio trend…